Case Number 3610
Request Date 02/05/2014
Completion Date 27/05/2014

 

Details of the Request

Within your organisation how many intra-vitreal injections/implants have been used between January and April 2014?

If injections are not known, please state the number of vials dispensed from your pharmacy in this period.

  • Lucentis (Ranibizumab) Injections
  • Avastin (Bevacizumab) Injections
  • Eylea (Aflibercept) Injections
  • Ozudex (Dexamethasone)
  • Implants
  • Total Injections / Implants
  • Vials / Implants

 

Does your organisation treat the following conditions ?

  • Wet Age Related Macular Degeneration (wAMD)
  • Visual impairment due to Diabetic Macular Oedema (DMO)
  • Retinal Vein Occlusion for Central Retinal Vein Occlusion (CRVO)
  • Retinal Vein Occlusion for Branch Retinal Vein Occlusion (BRVO)
  • Visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (mCNV)

 

Details of the Response

1) Within your organisation how many intra-vitreal injections/implants have been used between January and April 2014?

If injections are not known, please state the number of vials dispensed from your pharmacy in this period.

  Lucentis (Ranibizumab) Injections Avastin (Bevacizumab) Injections Eylea (Aflibercept) Injections Ozudex (Dexamethasone)
Implants Total Injections / Implants 0 0 0 23
Vials / Implants 723 33 0 0

 

2) Does your organisation treat the following conditions ?

  • Wet Age Related Macular Degeneration (wAMD)
  • Visual impairment due to Diabetic Macular Oedema (DMO)
  • Retinal Vein Occlusion for Central Retinal Vein Occlusion (CRVO)
  • Retinal Vein Occlusion for Branch Retinal Vein Occlusion (BRVO)
  • Visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (mCNV)

The Trust treats all the above conditions.